Facial Pain
Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
Subtype terms (1)
More specific conditions that are subtypes of Facial Pain in the MeSH hierarchy.
- Toothache
14 drugs (11 approved, 3 experimental)
Drugs by status
Phase 4 trials (11)
Phase 3 trials (4)
Phase 2 trials (5)
Phase 1 trials (3)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (13)
- Amgen
- Forest Laboratories
- National Institutes of Health (NIH)
- Hadassah Medical Organization
- Harvard University
- Duke University
- Federal University of Pelotas
- University of Washington
- Northwestern University
- Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- University of California, Los Angeles
- Hebrew University
- George Washington University
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (10)